Scholar argues for tele-prescription reforms that can increase patient access to necessary controlled substances.

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

The percentage of patients receiving medication for opioid use disorder in federally qualified health centers increased from 2017 to 2023.

The medications “help to bridge that gap between 'I want to get clean' and getting clean," a prisons official said.

For patients with psychiatric conditions from addiction to mood disorders such as depression, disrupted sleep can often exacerbate symptoms and make it harder to stay on treatment.

Story continues below this ad Although opioids have ... of pleasure that result from taking an opioid can also make people want to continue experiencing those feelings, which can contribute to ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

Suzetrigine is the first medication in its class to gain federal approval in over 20 years The approval of Journavx is particularly significant for Florida, where opioid addiction has become a ...

Vertex Pharmaceuticals (VRTX) stock rose on Friday after the Food and Drug Administration (FDA) approved its new painkiller, the first of its kind approved by regulators. Journavx, or suzetrigine ...

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction ... wave of the opioid epidemic is mainly due to illicit fentanyl, not pharmaceutical ...

The U.S. Food and Drug Administration (FDA) has approved a new drug for the treatment of moderate-to-severe pain that is a non-opioid and carries less risks of addiction than opioids. Journavx ...

WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and ...